Premier Medical names new chief scientific officer

LabPulse.com staff writers
Jul 27, 2021
2021 07 28 22 21 2792 2021 07 28 Brian Krueger 400

Premier Medical Laboratory Services has named Brian Krueger as its new chief scientific officer.

Krueger, the former technical director of research and development (R&D) at Labcorp, will be responsible for overseeing clinical assay development and communicating with the scientific and customer communities about laboratory capabilities, scientific product development, and the application of scientific research for medical advancements. Brian Krueger. Image courtesy of Premier Medical Laboratory Services.Brian Krueger. Image courtesy of Premier Medical Laboratory Services.
Latest in Research and Development
Heart Pulmonary Trunk Social
AI-powered blood test supports risk stratification of heart disease patients
November 27, 2023
Sepsis Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
November 22, 2023
Liver Anatomy Social
Bit.bio unveils cell therapy candidate for liver conditions
November 22, 2023
Bacteria Blood Sepsis Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
November 20, 2023
Related Stories
2020 02 08 00 11 9942 Virus Coronavirus 400
Health Topics
Premier Medical launches Virtual Lab
2020 01 21 22 13 2411 Virus Coronavirus 400
Emergency Use Authorization
Premier Medical to offer coronavirus testing
2019 04 17 00 53 3368 Dna Sequence 400
Product Launch
Premier Medical launches Patia's diabetes genetic test
2020 04 30 22 13 6857 Coronavirus Swab Ppe 400
Clinical Trial
Curebase, InBios tout results of virtual COVID-19 trial
More in Research and Development
AI-powered blood test supports risk stratification of heart disease patients
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
Heart Pulmonary Trunk Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Sepsis Bacteria Social
Bit.bio unveils cell therapy candidate for liver conditions
Synthetic biology company bit.bio has unveiled a lead cell therapy candidate as a treatment for life-threatening liver conditions, and it has set out its broader cell therapy pipeline.
November 22, 2023
Liver Anatomy Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Bacteria Blood Sepsis Social
PLK1 inhibitors show promise for inflammatory disease treatment, study shows
A cancer drug in late-stage clinical trials could offer hope for treating a wide range of inflammatory diseases, including gout and heart disease, say researchers.
November 14, 2023
Molecule Social
Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases
Genomics England and Oxford Nanopore Technologies have announced a strategic research partnership to resolve undiagnosed rare disease cases.
November 7, 2023
Cell Gene Therapy Dna Social
Pharma companies back project to create largest African ancestry genomics research database
AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.
October 25, 2023
Dna Genome Gene Targeted Social
Targeting feeder cells reverses prostate cancer’s resistance to treatment in study
Scientists have found a way to reverse prostate cancer’s resistance to drugs in research, which they say could have a broad impact across multiple cancer types.
October 24, 2023
Cancer Cells Prostate Social
Oxford Nanopore to receive $84.6M investment from BioMĂ©rieux, enters collaboration with Mayo Clinic
Oxford Nanopore is receiving a strategic investment of 70 million pounds ($84.6 million) from in vitro diagnostics (IVD) company BioMĂ©rieux. In addition, the firm has entered a collaboration with the Mayo Clinic on test development.
October 19, 2023
Research Money Social
ARUP launches new collaborative research institute
ARUP Industries is hoping to “push the boundaries of diagnostic medicine” via the launch of a new research institute that aims to forge collaborations with industry and community partners.
October 18, 2023
Lab Scientist Computer Ai Social
CMS opens new doors for cell and gene therapy under Medicaid
A new Medicaid-focused Innovation Center model encourages agreements between pharmaceutical companies and states for cell and gene therapies (CGT).
October 18, 2023
Sickle Cell Anemia2 Social
AI-driven method developed to identify therapeutic targets
Researchers have developed a method of identifying therapeutic targets for human diseases associated with protein phase separation that they say could be used to discover targets for Alzheimer’s and other neurogenerative diseases.
October 17, 2023
Artificial Intelligence Brain Social
Page 1 of 36
Next Page